RICC A/S: Financial statements 2024
CVR: 20690003
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
RICC A/S (CVR 20690003) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,314,000 and a net result of DKK 730,000 compared with DKK -2,757,000 the year before. That is a decrease of 98.3% compared with the year before. Equity in the 2024 report amounted to DKK 2,429,000. The solvency ratio was 12.1%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,314,000
- Profit/Loss
- DKK 730,000
- Equity
- DKK 2,429,000
- Total Assets
- DKK 20,127,000
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.3 mio. | 730 t. | 2.4 mio. | 5 |
| 2023 | - | 77 mio. | -2.8 mio. | 1.7 mio. | 42 |
| 2022 | - | 210.2 mio. | 9.3 mio. | 4.5 mio. | 57 |
| 2021 | - | 133.7 mio. | 4.5 mio. | -4.9 mio. | 70 |
| 2020 | - | 274.3 mio. | -155.8 mio. | -6 mio. | 63 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
RICC A/S has published its annual report for 2023. Gross profit came to DKK 76,967,000, and the net result was DKK -2,757,000.
On February 21, 2024, the company changed its name from ROCHE INNOVATION CENTER COPENHAGEN A/S to RICC A/S.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.